Studies on heart phosphofructokinase. Decavanadate as a potent allosteric inhibitor at alkaline and acidic pH.
D000494:Allosteric Regulation; D000495:Allosteric Site; D000818:Animals; D002951:Citrates / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004789:Enzyme Activation; D005958:Glucosephosphates / Q000494:pharmacology; D006598:Hexosediphosphates / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009206:Myocardium / Q000201:enzymology*; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D012756:Sheep; D014639:Vanadium / Q000494:pharmacology*
D002951:Citrates; D005958:Glucosephosphates; D006598:Hexosediphosphates; D014639:Vanadium; D000242:Cyclic AMP; D010732:Phosphofructokinase-1